LS Investment Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

LS Investment Advisors’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-57	Closed	-$3K	–	1673
2020 Q1	$3K	Sell	57 -932	-94%	-$51.9K	﹤0.01%	1678
2019 Q4	$60K	Buy	989 +57	+6%	+$3.4K	﹤0.01%	1266
2019 Q3	$56K	Hold	932	–	–	﹤0.01%	1274
2019 Q2	$60K	Buy	+932	New	+$65.9K	﹤0.01%	1249
2016 Q3	–	Sell	-2,411	Closed	-$56K	–	1862
2016 Q2	$56K	Buy	2,411 +569	+31%	+$18.4K	﹤0.01%	1167
2016 Q1	$75K	Hold	1,842	–	–	0.01%	986
2015 Q4	$114K	Hold	1,842	–	–	0.01%	813
2015 Q3	$74K	Hold	1,842	–	–	0.01%	977
2015 Q2	$106K	Hold	1,842	–	–	0.01%	856
2015 Q1	$117K	Buy	+1,842	New	+$125K	0.01%	664

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

LS Investment Advisors's IONS Position: Q2 2020 in Review

LS Investment Advisors sold out of Ionis Pharmaceuticals (IONS) in Q2 2020, closing a stake of 57 shares — an estimated $3K sold.

LS Investment Advisors first reported a position in IONS in Q1 2015 and held it in 10 quarters. The position peaked at $117K in Q1 2015. 375 funds tracked by Wall St. Rank hold IONS as of Q2 2020.

LS Investment Advisors reported no remaining Ionis Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
LS Investment Advisors sold 57 Ionis Pharmaceuticals shares in Q2 2020, an estimated $3K.
LS Investment Advisors first reported a position in Ionis Pharmaceuticals in Q1 2015 and held it in 10 quarters.
LS Investment Advisors's Ionis Pharmaceuticals position peaked at $117K in Q1 2015.
375 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2020.

Based on LS Investment Advisors's 13F filing for Q2 2020, filed 10 Aug 2020.